These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30039412)

  • 1. In Silico Screening of Compound Libraries Using a Consensus of Orthogonal Methodologies.
    Myrianthopoulos V; Lambrinidis G; Mikros E
    Methods Mol Biol; 2018; 1824():261-277. PubMed ID: 30039412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The compromise of virtual screening and its impact on drug discovery.
    Slater O; Kontoyianni M
    Expert Opin Drug Discov; 2019 Jul; 14(7):619-637. PubMed ID: 31025886
    [No Abstract]   [Full Text] [Related]  

  • 3. Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies.
    Poli G; Martinelli A; Tuccinardi T
    J Enzyme Inhib Med Chem; 2016; 31(sup2):167-173. PubMed ID: 27311630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening.
    Spiegel J; Senderowitz H
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to benchmark methods for structure-based virtual screening of large compound libraries.
    Christofferson AJ; Huang N
    Methods Mol Biol; 2012; 819():187-95. PubMed ID: 22183538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-silico guided discovery of novel CCR9 antagonists.
    Zhang X; Cross JB; Romero J; Heifetz A; Humphries E; Hall K; Wu Y; Stucka S; Zhang J; Chandonnet H; Lippa B; Ryan MD; Baber JC
    J Comput Aided Mol Des; 2018 Apr; 32(4):573-582. PubMed ID: 29582229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.
    Ma XH; Jia J; Zhu F; Xue Y; Li ZR; Chen YZ
    Comb Chem High Throughput Screen; 2009 May; 12(4):344-57. PubMed ID: 19442064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A facile consensus ranking approach enhances virtual screening robustness and identifies a cell-active DYRK1α inhibitor.
    Mavrogeni ME; Pronios F; Zareifi D; Vasilakaki S; Lozach O; Alexopoulos L; Meijer L; Myrianthopoulos V; Mikros E
    Future Med Chem; 2018 Oct; 10(20):2411-2430. PubMed ID: 30325204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Hybrid Virtual Screening Protocol Based on Binding Mode Similarity.
    Anighoro A; Bajorath J
    Methods Mol Biol; 2018; 1824():165-175. PubMed ID: 30039406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based drug screening and ligand-based drug screening with machine learning.
    Fukunishi Y
    Comb Chem High Throughput Screen; 2009 May; 12(4):397-408. PubMed ID: 19442067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors.
    Hoi PM; Li S; Vong CT; Tseng HH; Kwan YW; Lee SM
    Methods; 2015 Jan; 71():85-91. PubMed ID: 25239735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure.
    Zhang G; Wang K; Li XD; Zhang DL; Xu F
    Biomed Pharmacother; 2016 Dec; 84():147-157. PubMed ID: 27643557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repositioning by structure-based virtual screening.
    Ma DL; Chan DS; Leung CH
    Chem Soc Rev; 2013 Mar; 42(5):2130-41. PubMed ID: 23288298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery today.
    Schwardt O; Kolb H; Ernst B
    Curr Top Med Chem; 2003; 3(1):1-9. PubMed ID: 12570684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening of chemical libraries.
    Shoichet BK
    Nature; 2004 Dec; 432(7019):862-5. PubMed ID: 15602552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTiOpenScreen: a web server for structure-based virtual screening.
    Labbé CM; Rey J; Lagorce D; Vavruša M; Becot J; Sperandio O; Villoutreix BO; Tufféry P; Miteva MA
    Nucleic Acids Res; 2015 Jul; 43(W1):W448-54. PubMed ID: 25855812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking and Virtual Screening in Drug Discovery.
    Kontoyianni M
    Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting virtual screening enrichments with data fusion: coalescing hits from two-dimensional fingerprints, shape, and docking.
    Sastry GM; Inakollu VS; Sherman W
    J Chem Inf Model; 2013 Jul; 53(7):1531-42. PubMed ID: 23782297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
    Bar-Haim S; Aharon A; Ben-Moshe T; Marantz Y; Senderowitz H
    J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ; Meegan MJ; Carta G; Lloyd DG
    J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.